Breast cancer is the most common female cancer in the world, ranking first in most countries. It accounts for 23% of all female cancers and 10.9% of all human cancers worldwide. In Africa, there is regional variability: 16% in Senegal, 10% in the Republic of South Africa and 4% in Kenya. In Cameroon in 1992, breast cancer was second only to cervical, skin and liver cancer. In 2012 in the Yaounde population, breast cancer was the most common cancer in women with crude incidence rates and age-standardized. These Cameroonian studies, although they do not give the real prevalence and incidence of breast cancer in Cameroon, nevertheless show that this pathology has been on the rise in recent years (having risen from 2nd to 1st place in 10 years).
According to the researchers, “genomic sequencing to identify women at extremely high risk of breast cancer could be a very innovative approach to risk management and life-saving interventions”. This should encourage African countries to think about what they can do to combat the emerging cancer epidemic, using the capacity of science on the continent. Gene testing and analysis is becoming more and more accessible, allowing every African country to invest in genomic technologies”.
.
.
Pink October and the fight against breast cancer.
Let’s advance research, let’s participate together in the influence of the continent.
